{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:18:08Z","timestamp":1793215088309,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004433","name":"Chinese Pharmaceutical Association","doi-asserted-by":"publisher","award":["CPA-Z05-ZC-2022-002"],"award-info":[{"award-number":["CPA-Z05-ZC-2022-002"]}],"id":[{"id":"10.13039\/501100004433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["2023BCB030"],"award-info":[{"award-number":["2023BCB030"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204530"],"award-info":[{"award-number":["82204530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111592","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T06:22:13Z","timestamp":1706595733000},"page":"111592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synergistic effects and molecular mechanisms of DL-3-n-butylphthalide combined with dual antiplatelet therapy in acute ischemic stroke"],"prefix":"10.1016","volume":"129","author":[{"given":"Yujing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-4614","authenticated-orcid":false,"given":"Linjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongning","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-9748","authenticated-orcid":false,"given":"Xuejia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111592_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2024.111592_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/a-1339-7401","article-title":"New opportunities for diagnosis and prognosis of stroke: the benefits of across border approaches","volume":"41","author":"Vivien","year":"2021","journal-title":"Hamostaseologie."},{"key":"10.1016\/j.intimp.2024.111592_b0015","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/STROKEAHA.120.032810","article-title":"Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke","volume":"52","author":"Jolugbo","year":"2021","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.intimp.2024.111592_b0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000441098","article-title":"Stroke prevalence, mortality and disability-adjusted life years in adults aged 20\u201364 years in 1990\u20132013: Data from the global burden of disease 2013 study","volume":"45","author":"Krishnamurthi","year":"2015","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.intimp.2024.111592_b0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4103\/1673-5374.314319","article-title":"Inhibition of microRNA-29b suppresses oxidative stress and reduces apoptosis in ischemic stroke","volume":"17","author":"Ma","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2024.111592_b0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00018-020-03587-8","article-title":"Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury","volume":"78","author":"Lu","year":"2021","journal-title":"Cell. Mol. Life Sci. CMLS."},{"key":"10.1016\/j.intimp.2024.111592_b0035","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.2018.12498","article-title":"INTERRSeCT Study Investigators, Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke","volume":"320","author":"Menon","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2024.111592_b0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuropharm.2017.11.010","article-title":"Thrombolytic therapies for ischemic stroke: Triumphs and future challenges","volume":"134","author":"Moussaddy","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2024.111592_b0045","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1080\/10717544.2020.1850918","article-title":"Probing the drug delivery strategies in ischemic stroke therapy","volume":"27","author":"Wu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2024.111592_b0050","first-page":"5295","article-title":"Advances in pharmacology research of celery seed","volume":"34","author":"Qu","year":"2019","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.intimp.2024.111592_b0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/1673-5374.343892","article-title":"DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson\u2019s disease","volume":"18","author":"Hu","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2024.111592_b0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1871527317666180612125843","article-title":"Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke","volume":"17","author":"Wang","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.intimp.2024.111592_b0065","unstructured":"Chinese Society of Neurology, Chinese Stroke Society, Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018, Chin. J. Neurol. 51 (2018) 666\u2013682."},{"key":"10.1016\/j.intimp.2024.111592_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11940-021-00694-0","article-title":"Dual Antiplatelet Therapy in Ischemic Stroke Prevention: Which Two Could Be Better than One?","volume":"23","author":"Trifan","year":"2021","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.intimp.2024.111592_b0075","first-page":"114","article-title":"Application analysis of butylphthalide combined with double antibody in the treatment of elderly patients with cerebral infarction","volume":"7","author":"Yu","year":"2016","journal-title":"China Health Stand. Manag."},{"key":"10.1016\/j.intimp.2024.111592_b0080","first-page":"126","article-title":"Therapeutic Effect and Safety Evaluation of Dual Antiplatelet Combined with Butylphthalide Sequential Therapy for Acute Cerebral Infarction, China Foreign Med","volume":"37","author":"Zhang","year":"2018","journal-title":"Treat."},{"key":"10.1016\/j.intimp.2024.111592_b0085","first-page":"284","article-title":"Security analysis of butylphthalide combined with dual antiplatelet treatment on cerebral infarction in elderly","volume":"24","author":"Kong","year":"2016","journal-title":"J. Brain Nerv. Dis."},{"key":"10.1016\/j.intimp.2024.111592_b0090","first-page":"2866","article-title":"Efficacy and mechanism of butylphthalide combined with mouse nerve growth factor dual antibody therapy in the treatment of elderly patients with acute cerebral infarction, Guangxi","volume":"44","author":"Xu","year":"2022","journal-title":"Med. J."},{"key":"10.1016\/j.intimp.2024.111592_b0095","article-title":"Butylphthalide combined with dual antiplatelet therapy improves coagulation function and neurological function in patients with acute cerebral infarction","volume":"22","author":"Wu","year":"2022","journal-title":"J Trop. Med."},{"key":"10.1016\/j.intimp.2024.111592_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainresbull.2020.10.009","article-title":"Targeting pyroptosis to regulate ischemic stroke injury: Molecular mechanisms and preclinical evidences","volume":"165","author":"Ye","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2024.111592_b0105","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.111592_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bpa.12476","article-title":"A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?","volume":"27","author":"Barrington","year":"2017","journal-title":"Brain Pathol. Zurich Switz."},{"key":"10.1016\/j.intimp.2024.111592_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-8993(97)01008-1","article-title":"Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat","volume":"778","author":"Busch","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2024.111592_b0120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/hs0202.102950","article-title":"Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke","volume":"33","author":"Toomey","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2024.111592_b0125","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2147\/NDT.S314162","article-title":"Black Bamboo Rhizome Extract Improves Cognitive Dysfunction by Upregulating the Expression of Hippocampal BDNF and CREB in Rats with Cerebral Ischaemia-Reperfusion Injury","volume":"17","author":"Yi","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.intimp.2024.111592_b0130","first-page":"19","article-title":"Effect of dl-3n-butylphthalide on the Expression of caspase-3 in the Rat Model of Focal Cerebral Ischemia-reperfusion","author":"Jiao","year":"2007","journal-title":"Chin. J. Clin. Neurosci."},{"key":"10.1016\/j.intimp.2024.111592_b0135","first-page":"4734","article-title":"Effect of early hyperglycemia on the condition and prognosis of acute cerebral infarction","volume":"40","author":"Sun","year":"2020","journal-title":"Chin. J. Gerontol."},{"key":"10.1016\/j.intimp.2024.111592_b0140","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/cns.13978","article-title":"Efficacy and safety of 3-n-butylphthalide combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion","volume":"28","author":"Liu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2024.111592_b0145","doi-asserted-by":"crossref","first-page":"5012341","DOI":"10.1155\/2016\/5012341","article-title":"A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its Derivatives","volume":"2016","author":"Abdoulaye","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.intimp.2024.111592_b0150","unstructured":"Li H., Guo Q., Lv H., Effect of Butylphthalide Combined with Early Dual-antibody Therapy on Hemorheology and Inflammatory Factors in Elderly Patients with AIS, Chin. Foreign Med. Res. 20 (2022) 155\u2013158. 10.14033\/j.cnki.cfmr.2022.01.044."},{"key":"10.1016\/j.intimp.2024.111592_b0155","first-page":"1581","article-title":"Effects of butylphthalide combined with double antiplatelet on vascular endothelial function, angiogenesis index and hemorheology index in patients with acute cerebral infarction","volume":"22","author":"Miu","year":"2021","journal-title":"Chronic Pathematology J."},{"key":"10.1016\/j.intimp.2024.111592_b0160","first-page":"172","article-title":"Effect of early double antiplatelet regimen combined with butylphthalide in the treatment of patients with acute ischemic stroke","volume":"44","author":"Zhu","year":"2021","journal-title":"Heilongjiang Med. Pharm."},{"key":"10.1016\/j.intimp.2024.111592_b0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2024.111592_b0170","doi-asserted-by":"crossref","first-page":"1552127","DOI":"10.1155\/2021\/1552127","article-title":"Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia\/Macrophage Pyroptosis through NF-\u03baB Suppression and NLRP3 Inflammasome Inhibition","volume":"2021","author":"Ran","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.111592_b0175","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s12975-018-0666-3","article-title":"Gasdermin Family: a Promising Therapeutic Target for Stroke","volume":"9","author":"Chen","year":"2018","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.intimp.2024.111592_b0180","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11481-020-09978-9","article-title":"Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-\u03baB\/NLRP3 Pathway in Ischemic Stroke","volume":"16","author":"Li","year":"2021","journal-title":"J. Neuroimmune Pharmacol. off. J. Soc. Neuroimmune Pharmacol."},{"key":"10.1016\/j.intimp.2024.111592_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108146","article-title":"6-Gingerol protects against cerebral ischemia\/reperfusion injury by inhibiting NLRP3 inflammasome and apoptosis via TRPV1 \/ FAF1 complex dissociation-mediated autophagy","volume":"100","author":"Luo","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:47:03Z","timestamp":1769230023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S1567576924001103"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111592","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effects and molecular mechanisms of DL-3-n-butylphthalide combined with dual antiplatelet therapy in acute ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111592"}}